Back to VA VANGUARD CAPITAL MANAGEMENT LLC

ACRSACRS
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ACLARIS THERAPEUTICS INC

Yes. Vanguard Capital Management holds 5,817,866 shares of ACRS (Aclaris Therapeutics), worth $30.8M, as of its Q2 2026 13F filing. It increased the position by 650,397 shares (+12.6%) from Q1 2026. Vanguard Capital Management has held ACRS in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$30.8M

Current Shares

5.8M

Total Value Change

+$11.4M

Total Shares Change

+650,397

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.8M
+12.6%
$30.8M0.0%$5.29
32
2026-Q1
First report
5.2M
-
$19.4M0.0%$3.75
0

Other major holders of ACRS: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used